Examiner: RICCI, CRAIG D

Tech Center 1600 • Art Units: 1611 1614 1628

This examiner grants 54% of resolved cases

Performance Statistics

53.5%

Allow Rate

-6.5% vs TC avg

1,215

Total Applications

+52.8%

Interview Lift

1190

Avg Prosecution Days

Based on 1154 resolved cases, 2023–2026

1.2%

§101 Eligibility

17.2%

§102 Novelty

41.8%

§103 Obviousness

20.5%

§112 Clarity

App #	Title	Status	Assignee
19417018	SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY	Non-Final OA	Allergan, Inc.
18317725	METHODS OF TREATING HEAVY MENSTRUAL BLEEDING	Non-Final OA	AbbVie Inc.
17325900	METHODS OF TREATING HEAVY MENSTRUAL BLEEDING	Non-Final OA	AbbVie Inc.
18785975	HYDROPHILIC LINKERS FOR ANTIBODY DRUG CONJUGATES	Non-Final OA	REGENERON PHARMACEUTICALS, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.